BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37176165)

  • 1. GABA
    Nwosu GI; Shen W; Zavalin K; Poliquin S; Randhave K; Flamm C; Biven M; Langer K; Kang JQ
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
    Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
    Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA
    Qu S; Catron M; Zhou C; Janve V; Shen W; Howe RK; Macdonald RL
    Brain Commun; 2020; 2(1):fcaa028. PubMed ID: 32467926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous GABA
    Qu S; Jackson LG; Zhou C; Shen D; Shen W; Nwosu G; Howe R; Catron MA; Flamm C; Biven M; Kang JQ; Macdonald RL
    Epilepsia; 2023 Apr; 64(4):1061-1073. PubMed ID: 36495145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy.
    Papandreou A; McTague A; Trump N; Ambegaonkar G; Ngoh A; Meyer E; Scott RH; Kurian MA
    Dev Med Child Neurol; 2016 Apr; 58(4):416-20. PubMed ID: 26645412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric Slow-Spike-Wave Patterns with Maximal Discharges Contralateral to MRI Lesions Predict Better Surgical Prognosis in Symptomatic Lennox-Gastaut Syndrome or Lennox-Gastaut Phenotypes.
    Yang MH; Liu J; Zhou YL; Yang H; Cai FC; Zempel J; Yang QW; Liu SY
    Pediatr Neurosurg; 2020; 55(1):26-35. PubMed ID: 31851997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
    DeLorey TM; Olsen RW
    Epilepsy Res; 1999 Sep; 36(2-3):123-32. PubMed ID: 10515160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.
    Nightscales R; Chen Z; Barnard S; Auvrez C; Tao G; Sivathamboo S; Bennett C; Rychkova M; D'Souza W; Berkovic SF; Nicolo JP; O'Brien TJ; Perucca P; Scheffer IE; Kwan P
    Epilepsia Open; 2024 Apr; 9(2):602-612. PubMed ID: 38135919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.
    Dupont S; Banica-Wolters R; An-Gourfinkel I; Lambrecq V; Navarro V; Adam C; Nguyen-Michel VH
    J Neurol; 2017 Jul; 264(7):1388-1396. PubMed ID: 28584915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
    Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
    Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lennox Gastaut Syndrome - A strategic shift in diagnosis over time?
    Evans NJ; Das K
    Seizure; 2022 Dec; 103():68-71. PubMed ID: 36332460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
    Janve VS; Hernandez CC; Verdier KM; Hu N; Macdonald RL
    Ann Neurol; 2016 May; 79(5):806-825. PubMed ID: 26950270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity.
    Lin SXN; Ahring PK; Keramidas A; Liao VWY; Møller RS; Chebib M; Absalom NL
    Brain; 2024 Jan; 147(1):224-239. PubMed ID: 37647766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD2 mutations in Lennox-Gastaut syndrome.
    Lund C; Brodtkorb E; Øye AM; Røsby O; Selmer KK
    Epilepsy Behav; 2014 Apr; 33():18-21. PubMed ID: 24614520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleft Palate as Distinguishing Feature in a Patient with GABRB3 Epileptic Encephalopathy.
    Bamborschke D; Pergande M; Daimagüler HS; Mangold E; Dötsch J; Herkenrath P; Cirak S; Fazeli W
    Neuropediatrics; 2019 Dec; 50(6):378-381. PubMed ID: 31319422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.
    DeLorey TM; Handforth A; Anagnostaras SG; Homanics GE; Minassian BA; Asatourian A; Fanselow MS; Delgado-Escueta A; Ellison GD; Olsen RW
    J Neurosci; 1998 Oct; 18(20):8505-14. PubMed ID: 9763493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome.
    Berg AT; Levy SR; Testa FM
    Epilepsia; 2018 Nov; 59(11):2096-2105. PubMed ID: 30255934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset epileptic encephalopathy with a novel GABRB3 mutation treated effectively with clonazepam: A case report.
    Zhang Y; Lian Y; Xie N
    Medicine (Baltimore); 2017 Dec; 96(50):e9273. PubMed ID: 29390378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unchanging face of Lennox-Gastaut syndrome in adulthood.
    Reyhani A; Özkara Ç
    Epilepsy Res; 2021 May; 172():106575. PubMed ID: 33721709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.